van Vollenhoven, R. F., Petri, M. A., Cervera, R., Roth, D. A., Ji, B. N., Kleoudis, C. S., . . . Freimuth, W. (2012). Belimumab in the treatment of systemic lupus erythematosus: High disease activity predictors of response. BMJ Group.
Chicago Style Citationvan Vollenhoven, Ronald F., Michelle A. Petri, Ricard Cervera, David A. Roth, Beulah N. Ji, Christi S. Kleoudis, Z John Zhong, and William Freimuth. Belimumab in the Treatment of Systemic Lupus Erythematosus: High Disease Activity Predictors of Response. BMJ Group, 2012.
MLA Citationvan Vollenhoven, Ronald F., et al. Belimumab in the Treatment of Systemic Lupus Erythematosus: High Disease Activity Predictors of Response. BMJ Group, 2012.
Warning: These citations may not always be 100% accurate.